252 related articles for article (PubMed ID: 11405802)
1. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.
Yamamoto AM; Gajdos P; Eymard B; Tranchant C; Warter JM; Gomez L; Bourquin C; Bach JF; Garchon HJ
Arch Neurol; 2001 Jun; 58(6):885-90. PubMed ID: 11405802
[TBL] [Abstract][Full Text] [Related]
2. Titin, thymoma, and myasthenia gravis.
Aarli JA
Arch Neurol; 2001 Jun; 58(6):869-70. PubMed ID: 11405799
[No Abstract] [Full Text] [Related]
3. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
Chen XJ; Qiao J; Xiao BG; Lu CZ
J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
[TBL] [Abstract][Full Text] [Related]
4. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
5. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
6. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
7. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
8. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
9. [Anti-Titin-antibodies at the patients with myasthenic and non-myasthenic thymoma].
Vetshev PS; Sanadze AG; Sidnev DV; Ippolitov LI; Zhivotov VA; Ablitsov AIu
Khirurgiia (Mosk); 2007; (6):53-6. PubMed ID: 17690667
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
11. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
[TBL] [Abstract][Full Text] [Related]
12. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Eur J Neurol; 2002 Jan; 9(1):55-61. PubMed ID: 11784377
[TBL] [Abstract][Full Text] [Related]
13. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur Neurol; 2003; 49(4):210-7. PubMed ID: 12736536
[TBL] [Abstract][Full Text] [Related]
14. Muscle autoantibodies in subgroups of myasthenia gravis patients.
Romi F; Skeie GO; Aarli JA; Gilhus NE
J Neurol; 2000 May; 247(5):369-75. PubMed ID: 10896269
[TBL] [Abstract][Full Text] [Related]
15. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
[TBL] [Abstract][Full Text] [Related]
16. Thymus, thymoma and myasthenia gravis.
Fujii Y
Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
[TBL] [Abstract][Full Text] [Related]
17. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
Buckley C; Newsom-Davis J; Willcox N; Vincent A
Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
[TBL] [Abstract][Full Text] [Related]
18. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
[TBL] [Abstract][Full Text] [Related]
19. [Serum anti-titin antibody in patients with myasthenia gravis].
Li YF; Zhang JB; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970-1999.
Somnier FE; Engel PJ
Neurology; 2002 Jul; 59(1):92-8. PubMed ID: 12105313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]